Recombinant A. caninum NIF Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 5845-NF
Key Product Details
- R&D Systems NS0-derived Recombinant A. caninum NIF Protein (5845-NF)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Product Specifications
Source
Asn18-Leu274, with a C-terminal 6-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is 0.1-0.4 μg/mL.
Also measured by its ability to bind Recombinant Human Integrin alphaM beta2 (Catalog # 4047-AM) in a functional ELISA.
Reviewed Applications
Read 1 review rated 5 using 5845-NF in the following applications:
Formulation, Preparation and Storage
5845-NF
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS, NaCl, and DTT. |
| Reconstitution |
Reconstitute at 200 μg/mL in PBS.
|
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: NIF
Neutrophil inhibitory factor (NIF) of the dog hookworm, Ancylostoma caninum, is a 41 kDa secreted glycoprotein that is thought to allow the hookworm to evade the innate immune defenses of the host (1, 2). NIF interacts with the leukocyte integrin alphaM beta2 (CD11b/CD18, also called Mac-1), thus inhibiting mammalian neutrophil adhesion to endothelium (1). The A. caninum NIF cDNA encodes 257 amino acids (aa) including a 17 aa signal sequence and a 240 aa mature protein with 10 cysteine residues and 7 potential N-linked glycosylation sites (1). Incubation of mammalian neutrophils with NIF does not appear to be toxic, but does result in rapid, cation‑dependent, reversible inhibition of alphaM beta2-mediated adhesion and degranulation (1 - 4). The NIF binding site within the alphaM beta2 I-domain interferes with activation‑dependent adhesion sites of ligands including ICAM-1/CD54, complement component C3b, and fibrinogen (2, 3). In mouse or guinea pig inflammatory lung injury models, administration of NIF prevented neutrophil-dependent vascular injury (4, 5).
References
- Moyle, M. et al. (1994) J. Biol. Chem. 269:10008.
- Rieu, P. et al. (1994) J. Cell Biol. 127:2081.
- Ustinov, V.A. and E.F. Plow (2002) J. Biol. Chem. 277:18769.
- Barnard, J.W. et al. (1995) J. Immunol. 155:4876.
- Zhou, M.-Y. et al. (1998) J. Clin. Invest. 101:2427.
Long Name
UniProt
Additional NIF Products
Product Documents for Recombinant A. caninum NIF Protein, CF
Product Specific Notices for Recombinant A. caninum NIF Protein, CF
For research use only